John James O'Connor - Dec 4, 2025 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role: Director
Signature: /s/ Laurie A. Churchill, Attorney-in-fact
Stock symbol: LMAT
Transactions as of: Dec 4, 2025
Transactions value $: $0
Form type: 4
Date filed: 12/8/2025, 08:22 PM
Previous filing: Nov 21, 2025
Next filing: Dec 10, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
O'Connor John James	Director	C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON	/s/ Laurie A. Churchill, Attorney-in-fact	2025-12-08	0001382475

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LMAT	Common Stock	Gift	$0	-3K	-4.63%	$0.00	61.8K	Dec 4, 2025	Direct
transaction	LMAT	Common Stock	Options Exercise	$0	+1	+0%	$0.00	61.8K	Dec 6, 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LMAT	Dividend Equivalent Rights	Award	$0	+0.474	+7.26%	$0.00	6.99	Dec 4, 2025	Common Stock	0.474		Direct	F2
transaction	LMAT	Dividend Equivalent Rights	Award	$0	+0.474	+8.56%	$0.00	6	Dec 4, 2025	Common Stock	0.474		Direct	F3
transaction	LMAT	Dividend Equivalent Rights	Award	$0	+0.81	+15%	$0.00	6.21	Dec 4, 2025	Common Stock	0.81		Direct	F4
transaction	LMAT	Dividend Equivalent Rights	Award	$0	+0.97	+16.53%	$0.00	6.84	Dec 4, 2025	Common Stock	0.97		Direct	F5
transaction	LMAT	Dividend Equivalent Rights	Award	$0	+0.987	+33.91%	$0.00	3.9	Dec 4, 2025	Common Stock	0.987		Direct	F6
transaction	LMAT	Dividend Equivalent Rights	Options Exercise	$0	-1	-25.64%	$0.00	2.9	Dec 6, 2025	Common Stock	1		Direct	F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
F2	These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F3	These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F4	These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F5	These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F6	These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F7	These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/6/2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.